Cacna1d Conditional Knockout mouse models
Cacna1d, ortholog of human CACNA1D, encodes CaV1.3, an L-type α1D channel distinguished from CaV1.2 by activation at markedly more negative potentials and by weak dihydropyridine sensitivity, properties that make it the pacemaking current in sinoatrial and adrenal chromaffin cells and the sole channel gating tonic glutamate release at cochlear inner hair cell ribbon synapses. Extensive C-terminal alternative splicing and a modulatory C-terminal domain tune calcium-dependent inactivation, and human alleles split cleanly by direction: recessive loss of function produces sinoatrial node dysfunction with deafness, whereas somatic and germline gain-of-function substitutions such as A749G cause aldosterone-producing adenomas and primary aldosteronism with seizures and neurologic disability. Constitutive nulls are viable but deaf and bradycardic, giving a tractable model, while a gain-of-function knockin isolates the aldosterone and neurodevelopmental arm. CaV1.2 compensates in several tissues, so quantify Cacna1c transcript and current before attributing residual L-type conductance.
Tissue restricted knockout of Cacna1d keeps wild type function everywhere else. Breeding is often more robust, and the setup mirrors patient biology where mutations arise in a subset of cells.
What Cacna1d Conditional Knockout mouse models are available?
ingenious targeting laboratory offers 1 distinct Cacna1d conditional knockout catalog mouse model. Researchers can order pre-developed catalog lines or request a custom mouse model, including humanized, knockin, and transgenic variations with verified germline transmission.
Catalog table
| Model | Type | Category | Availability | Catalog # | Action |
|---|---|---|---|---|---|
| Cacna1d-Flox | Conditional Knockout | KO/CKO mice | sperm cryopreservation | CKO 205087 | Inquire |
Why this approach
Conditional knockout focuses the experiment on your target tissue while the rest of the animal keeps a wild type allele. That pattern mirrors somatic mutation in patients and avoids systemic compensation that can erase subtle phenotypes. It is often preferred when a germline null is lethal, weak, or confounded by developmental rescue.
Pricing and quotes
The Cacna1d Conditional Knockout lines listed above are catalog models. Send us the catalog number and our team confirms current availability, pricing, and whether the line ships cryopreserved or live.
If your study needs a Cacna1d allele configuration that is not listed above, our scientific team designs and generates it. Model generation quotes return in about twenty four hours with project milestones and pricing.
FAQ
What Cacna1d Conditional Knockout mouse models are available?
When Cacna1d Conditional Knockout lines are in catalog, we ship from inventory. If your configuration is not listed, we design the allele to order. Common paths include conditional knockout, constitutive knockout, humanized, knockin, and transgenic options, with documented germline transmission and United States QC.
Is Cacna1d knockout embryonic lethal in mice?
It depends on background and allele design. Some Cacna1d germline knockouts are viable. Others need conditional alleles or mixed backgrounds. We review publications and our own experience, then recommend floxed versus null before you commit.
Which Cre driver is best for experiments?
Driver choice depends on onset timing, recombination efficiency, and known leak. We map your organ and cell type to a short list of proven Cre lines, then talk through reporter crosses and controls. We favor drivers with strong community validation for your tissue.
Do you ship live Cacna1d animals?
When catalog lines are live, we ship with health certificates and QC documentation. If your exact combo is not listed, we quote a generation project with cryo or live dispatch depending on cohort timing and geography.
How do I request a quote for Cacna1d?
Use the catalog inquire buttons or the request quote form. Include your allele goal, Cre plan if any, strain background, and cohort size. A PhD led team responds with pricing, milestones, and the fastest path to experimental animals.